Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Fabry Disease Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Fabry Disease Therapeuticmarket, defines the market attractiveness level of Fabry Disease Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Fabry Disease Therapeutic industry, describes the types of Fabry Disease Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Fabry Disease Therapeutic market and the development prospects and opportunities of Fabry Disease Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Fabry Disease Therapeutic market in Chapter 13.
By Player:
Protalix
GlaxoSmithKline plc
Amgen Inc
Novartis Pharmaceuticals
Green Cross Corp
AbbVie Inc
Pfizer
Shire
Merc & Co
Amicus therapeutics
Sanofi-Aventis LLC
Genzyme-Sanofi
Takeda Pharmaceutical Co Ltd
Teva pharmaceutical Industries Ltd
Bristol-Myers Squibb Company
By Type:
Enzyme Replacement Therapy
Alternative therapies
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Fabry Disease Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Fabry Disease Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Fabry Disease Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Fabry Disease Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Fabry Disease Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Fabry Disease Therapeutic Consumption (2017-2022)
-
7.2 United States Fabry Disease Therapeutic Consumption (2017-2022)
-
7.3 Europe Fabry Disease Therapeutic Consumption (2017-2022)
-
7.4 China Fabry Disease Therapeutic Consumption (2017-2022)
-
7.5 Japan Fabry Disease Therapeutic Consumption (2017-2022)
-
7.6 India Fabry Disease Therapeutic Consumption (2017-2022)
-
7.7 South Korea Fabry Disease Therapeutic Consumption (2017-2022)
8 Region and Country-wise Fabry Disease Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Fabry Disease Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Fabry Disease Therapeutic Consumption Forecast (2022-2028)
9 Global Fabry Disease Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Fabry Disease Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Enzyme Replacement Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alternative therapies Consumption and Growth Rate (2017-2022)
-
9.2 Global Fabry Disease Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Fabry Disease Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Fabry Disease Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Enzyme Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alternative therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Fabry Disease Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Fabry Disease Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Fabry Disease Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Fabry Disease Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Fabry Disease Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Fabry Disease Therapeutic Market Competitive Analysis
-
14.1 Protalix
-
14.1.1 Protalix Company Details
-
14.1.2 Protalix Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Protalix Fabry Disease Therapeutic Product and Service
-
14.2 GlaxoSmithKline plc
-
14.2.1 GlaxoSmithKline plc Company Details
-
14.2.2 GlaxoSmithKline plc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline plc Fabry Disease Therapeutic Product and Service
-
14.3 Amgen Inc
-
14.3.1 Amgen Inc Company Details
-
14.3.2 Amgen Inc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Inc Fabry Disease Therapeutic Product and Service
-
14.4 Novartis Pharmaceuticals
-
14.4.1 Novartis Pharmaceuticals Company Details
-
14.4.2 Novartis Pharmaceuticals Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Product and Service
-
14.5 Green Cross Corp
-
14.5.1 Green Cross Corp Company Details
-
14.5.2 Green Cross Corp Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Green Cross Corp Fabry Disease Therapeutic Product and Service
-
14.6 AbbVie Inc
-
14.6.1 AbbVie Inc Company Details
-
14.6.2 AbbVie Inc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Inc Fabry Disease Therapeutic Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Fabry Disease Therapeutic Product and Service
-
14.8 Shire
-
14.8.1 Shire Company Details
-
14.8.2 Shire Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire Fabry Disease Therapeutic Product and Service
-
14.9 Merc & Co
-
14.9.1 Merc & Co Company Details
-
14.9.2 Merc & Co Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merc & Co Fabry Disease Therapeutic Product and Service
-
14.10 Amicus therapeutics
-
14.10.1 Amicus therapeutics Company Details
-
14.10.2 Amicus therapeutics Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Amicus therapeutics Fabry Disease Therapeutic Product and Service
-
14.11 Sanofi-Aventis LLC
-
14.11.1 Sanofi-Aventis LLC Company Details
-
14.11.2 Sanofi-Aventis LLC Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Product and Service
-
14.12 Genzyme-Sanofi
-
14.12.1 Genzyme-Sanofi Company Details
-
14.12.2 Genzyme-Sanofi Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Genzyme-Sanofi Fabry Disease Therapeutic Product and Service
-
14.13 Takeda Pharmaceutical Co Ltd
-
14.13.1 Takeda Pharmaceutical Co Ltd Company Details
-
14.13.2 Takeda Pharmaceutical Co Ltd Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Takeda Pharmaceutical Co Ltd Fabry Disease Therapeutic Product and Service
-
14.14 Teva pharmaceutical Industries Ltd
-
14.14.1 Teva pharmaceutical Industries Ltd Company Details
-
14.14.2 Teva pharmaceutical Industries Ltd Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Teva pharmaceutical Industries Ltd Fabry Disease Therapeutic Product and Service
-
14.15 Bristol-Myers Squibb Company
-
14.15.1 Bristol-Myers Squibb Company Company Details
-
14.15.2 Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Fabry Disease Therapeutic
-
Figure Fabry Disease Therapeutic Picture
-
Table Global Fabry Disease Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fabry Disease Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Fabry Disease Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Fabry Disease Therapeutic Consumption by Country (2017-2022)
-
Figure United States Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Fabry Disease Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Fabry Disease Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Fabry Disease Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Replacement Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Alternative therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alternative therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Fabry Disease Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Fabry Disease Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Protalix (Foundation Year, Company Profile and etc.)
-
Table Protalix Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix Fabry Disease Therapeutic Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Fabry Disease Therapeutic Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Fabry Disease Therapeutic Product and Service
-
Table Novartis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Novartis Pharmaceuticals Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharmaceuticals Fabry Disease Therapeutic Product and Service
-
Table Green Cross Corp (Foundation Year, Company Profile and etc.)
-
Table Green Cross Corp Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Green Cross Corp Fabry Disease Therapeutic Product and Service
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Fabry Disease Therapeutic Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Fabry Disease Therapeutic Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Fabry Disease Therapeutic Product and Service
-
Table Merc & Co (Foundation Year, Company Profile and etc.)
-
Table Merc & Co Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merc & Co Fabry Disease Therapeutic Product and Service
-
Table Amicus therapeutics (Foundation Year, Company Profile and etc.)
-
Table Amicus therapeutics Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus therapeutics Fabry Disease Therapeutic Product and Service
-
Table Sanofi-Aventis LLC (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis LLC Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis LLC Fabry Disease Therapeutic Product and Service
-
Table Genzyme-Sanofi (Foundation Year, Company Profile and etc.)
-
Table Genzyme-Sanofi Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme-Sanofi Fabry Disease Therapeutic Product and Service
-
Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Co Ltd Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Co Ltd Fabry Disease Therapeutic Product and Service
-
Table Teva pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva pharmaceutical Industries Ltd Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva pharmaceutical Industries Ltd Fabry Disease Therapeutic Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Fabry Disease Therapeutic Product and Service
-
